USA Glutamate Receptor Ionotropic NMDA 2B Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Glutamate Receptor Ionotropic NMDA 2B market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Glutamate Receptor Ionotropic NMDA 2B market. Detailed analysis of key players, along with key growth strategies adopted by Glutamate Receptor Ionotropic NMDA 2B industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • UCB SA

    • Bristol-Myers Squibb Company

    • BioCrea GmbH

    • Cerecor Inc

    • Novartis AG

    • NeurOp, Inc

    • Luc Therapeutics, Inc

    • Johnson & Johnson

    By Type:

    • JNJ-0808

    • Neu-2000

    • NP-10679

    • NP-11948

    • Radiprodil

    • Others

    By End-User:

    • Acute Ischemic Stroke

    • Autism

    • Brasin Ischemia

    • Burns

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Glutamate Receptor Ionotropic NMDA 2B Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of JNJ-0808 from 2016 to 2027

      • 1.3.2 USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Neu-2000 from 2016 to 2027

      • 1.3.3 USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of NP-10679 from 2016 to 2027

      • 1.3.4 USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of NP-11948 from 2016 to 2027

      • 1.3.5 USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Radiprodil from 2016 to 2027

      • 1.3.6 USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Acute Ischemic Stroke from 2016 to 2027

      • 1.4.2 USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Autism from 2016 to 2027

      • 1.4.3 USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Brasin Ischemia from 2016 to 2027

      • 1.4.4 USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Burns from 2016 to 2027

      • 1.4.5 USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Glutamate Receptor Ionotropic NMDA 2B Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Glutamate Receptor Ionotropic NMDA 2B Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Glutamate Receptor Ionotropic NMDA 2B by Major Types

      • 3.4.1 Market Size and Growth Rate of JNJ-0808

      • 3.4.2 Market Size and Growth Rate of Neu-2000

      • 3.4.3 Market Size and Growth Rate of NP-10679

      • 3.4.4 Market Size and Growth Rate of NP-11948

      • 3.4.5 Market Size and Growth Rate of Radiprodil

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Glutamate Receptor Ionotropic NMDA 2B Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Glutamate Receptor Ionotropic NMDA 2B by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Glutamate Receptor Ionotropic NMDA 2B in Acute Ischemic Stroke

      • 4.4.2 Market Size and Growth Rate of Glutamate Receptor Ionotropic NMDA 2B in Autism

      • 4.4.3 Market Size and Growth Rate of Glutamate Receptor Ionotropic NMDA 2B in Brasin Ischemia

      • 4.4.4 Market Size and Growth Rate of Glutamate Receptor Ionotropic NMDA 2B in Burns

      • 4.4.5 Market Size and Growth Rate of Glutamate Receptor Ionotropic NMDA 2B in Others

    5 Market Analysis by Regions

    • 5.1 USA Glutamate Receptor Ionotropic NMDA 2B Production Analysis by Regions

    • 5.2 USA Glutamate Receptor Ionotropic NMDA 2B Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis

    • 6.1 West USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis by Major Types

    • 6.2 West USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis by Major End-Users

    7 South USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis

    • 7.1 South USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis by Major Types

    • 7.2 South USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis by Major End-Users

    8 Middle West USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis

    • 8.1 Middle West USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis by Major Types

    • 8.2 Middle West USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis by Major End-Users

    9 Northeast USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis

    • 9.1 Northeast USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis by Major Types

    • 9.2 Northeast USA Glutamate Receptor Ionotropic NMDA 2B Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 UCB SA

        • 10.1.1 UCB SA Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Bristol-Myers Squibb Company

        • 10.2.1 Bristol-Myers Squibb Company Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 BioCrea GmbH

        • 10.3.1 BioCrea GmbH Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Cerecor Inc

        • 10.4.1 Cerecor Inc Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Novartis AG

        • 10.5.1 Novartis AG Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 NeurOp, Inc

        • 10.6.1 NeurOp, Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Luc Therapeutics, Inc

        • 10.7.1 Luc Therapeutics, Inc Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Johnson & Johnson

        • 10.8.1 Johnson & Johnson Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of JNJ-0808 from 2016 to 2027

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Neu-2000 from 2016 to 2027

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of NP-10679 from 2016 to 2027

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of NP-11948 from 2016 to 2027

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Radiprodil from 2016 to 2027

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Acute Ischemic Stroke from 2016 to 2027

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Autism from 2016 to 2027

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Brasin Ischemia from 2016 to 2027

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Burns from 2016 to 2027

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Glutamate Receptor Ionotropic NMDA 2B Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Glutamate Receptor Ionotropic NMDA 2B Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Glutamate Receptor Ionotropic NMDA 2B

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Glutamate Receptor Ionotropic NMDA 2B by Different Types from 2016 to 2027

    • Table Consumption Share of Glutamate Receptor Ionotropic NMDA 2B by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of JNJ-0808

    • Figure Market Size and Growth Rate of Neu-2000

    • Figure Market Size and Growth Rate of NP-10679

    • Figure Market Size and Growth Rate of NP-11948

    • Figure Market Size and Growth Rate of Radiprodil

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Glutamate Receptor Ionotropic NMDA 2B by Different End-Users from 2016 to 2027

    • Table Consumption Share of Glutamate Receptor Ionotropic NMDA 2B by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Acute Ischemic Stroke

    • Figure Market Size and Growth Rate of Autism

    • Figure Market Size and Growth Rate of Brasin Ischemia

    • Figure Market Size and Growth Rate of Burns

    • Figure Market Size and Growth Rate of Others

    • Table USA Glutamate Receptor Ionotropic NMDA 2B Production by Regions

    • Table USA Glutamate Receptor Ionotropic NMDA 2B Production Share by Regions

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Production Share by Regions in 2016

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Production Share by Regions in 2021

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Production Share by Regions in 2027

    • Table USA Glutamate Receptor Ionotropic NMDA 2B Consumption by Regions

    • Table USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Regions

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Regions in 2016

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Regions in 2021

    • Figure USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Regions in 2027

    • Table West USA Glutamate Receptor Ionotropic NMDA 2B Consumption by Types from 2016 to 2027

    • Table West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types from 2016 to 2027

    • Figure West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2016

    • Figure West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2021

    • Figure West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2027

    • Table West USA Glutamate Receptor Ionotropic NMDA 2B Consumption by End-Users from 2016 to 2027

    • Table West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2016

    • Figure West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2021

    • Figure West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2027

    • Table South USA Glutamate Receptor Ionotropic NMDA 2B Consumption by Types from 2016 to 2027

    • Table South USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types from 2016 to 2027

    • Figure South USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2016

    • Figure South USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2021

    • Figure South USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2027

    • Table South USA Glutamate Receptor Ionotropic NMDA 2B Consumption by End-Users from 2016 to 2027

    • Table South USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2016

    • Figure South USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2021

    • Figure South USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2027

    • Table Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption by Types from 2016 to 2027

    • Table Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2016

    • Figure Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2021

    • Figure Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2027

    • Table Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2016

    • Figure Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2021

    • Figure Middle West USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2027

    • Table Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption by Types from 2016 to 2027

    • Table Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2016

    • Figure Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2021

    • Figure Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by Types in 2027

    • Table Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2016

    • Figure Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2021

    • Figure Northeast USA Glutamate Receptor Ionotropic NMDA 2B Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of UCB SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB SA

    • Figure Sales and Growth Rate Analysis of UCB SA

    • Figure Revenue and Market Share Analysis of UCB SA

    • Table Product and Service Introduction of UCB SA

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company

    • Table Product and Service Introduction of Bristol-Myers Squibb Company

    • Table Company Profile and Development Status of BioCrea GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCrea GmbH

    • Figure Sales and Growth Rate Analysis of BioCrea GmbH

    • Figure Revenue and Market Share Analysis of BioCrea GmbH

    • Table Product and Service Introduction of BioCrea GmbH

    • Table Company Profile and Development Status of Cerecor Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cerecor Inc

    • Figure Sales and Growth Rate Analysis of Cerecor Inc

    • Figure Revenue and Market Share Analysis of Cerecor Inc

    • Table Product and Service Introduction of Cerecor Inc

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of NeurOp, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NeurOp, Inc

    • Figure Sales and Growth Rate Analysis of NeurOp, Inc

    • Figure Revenue and Market Share Analysis of NeurOp, Inc

    • Table Product and Service Introduction of NeurOp, Inc

    • Table Company Profile and Development Status of Luc Therapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Luc Therapeutics, Inc

    • Figure Sales and Growth Rate Analysis of Luc Therapeutics, Inc

    • Figure Revenue and Market Share Analysis of Luc Therapeutics, Inc

    • Table Product and Service Introduction of Luc Therapeutics, Inc

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.